A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.

Excerpts and summaries of news stories from the former Intelligencer Journal, Lancaster New Era and Sunday News that focus on ...

A new council-backed solar energy farm looks set to be built in Lancashire after councillors approved an application. Plans ...

A group of Lancaster University engineering students has been shortlisted for a prestigious national award for their ...

A former Lancaster University student who was determined to be a film-maker has pushed boundaries and realised his ambition.

Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...

A whirlwind week for Chad Ryland ended with him kicking a game-winning field goal. The Cedar Crest grad, signed by the ...

“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...